VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund 6.56M Jun 30, 2026 1.22% 24,948,845 ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The rise of generative AI and agentic AI, with AI coding tools capabilities, has created a ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Stack Overflow is privately owned by Prosus and is not publicly traded. Invest in Prosus to gain indirect exposure to Stack Overflow’s growth and AI integration. Prosus also offers exposure through ...
Salt Lake City, UT, Oct. 15, 2026 (GLOBE NEWSWIRE) — Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and development ...
The company this week announced a new 72MW campus in Leesburg. Known as NVA-06, the 32-acre site will initially host a 48MW building set to deliver Q2 2025, followed by a second 24MW building to ...
The company this week announced plans to develop a 220MW campus south of Dallas in Lancaster. The campus, known as DFW2, spans over 100 acres and is set to accommodate both shell and turnkey ...
You're currently following this author! Click to unsubscribe from email alerts. This as-told-to essay is based on a conversation with Amy Suto, a 32-year-old freelance writer based in San Francisco.
View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results